These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26333938)

  • 1. Development and optimisation of mucoadhesive nanoparticles of acyclovir using design of experiments approach.
    Kharia AA; Singhai AK
    J Microencapsul; 2015; 32(6):521-32. PubMed ID: 26333938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective parameters for formulation of gastro adhesive nanoparticles: screening by design-of-experiments approach.
    Kharia AA; Singhai AK
    J Microencapsul; 2014; 31(4):399-405. PubMed ID: 24697180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
    Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
    Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.
    Dhaliwal S; Jain S; Singh HP; Tiwary AK
    AAPS J; 2008 Jun; 10(2):322-30. PubMed ID: 18523891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.
    Sankar R; Jain SK
    Drug Des Devel Ther; 2013; 7():1455-69. PubMed ID: 24348022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
    Liu H; Pan W; Ke P; Dong Y; Ji L
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes.
    Ramyadevi D; Rajan KS; Vedhahari BN; Ruckmani K; Subramanian N
    Colloids Surf B Biointerfaces; 2016 Oct; 146():260-70. PubMed ID: 27351137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of statistical experimental design to improve entrapment efficiency of acyclovir in poly (d, l) lactide nanoparticles.
    Patel PJ; Gohel MC; Acharya SR
    Pharm Dev Technol; 2014 Mar; 19(2):200-12. PubMed ID: 23432525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving oral bioavailability of acyclovir using nanoparticulates of thiolated xyloglucan.
    Madgulkar A; Bhalekar MR; Dikpati AA
    Int J Biol Macromol; 2016 Aug; 89():689-99. PubMed ID: 27026342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
    Seyfoddin A; Al-Kassas R
    Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.
    Gandhi A; Jana S; Sen KK
    Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
    Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
    El-Habashy SE; Allam AN; El-Kamel AH
    Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir.
    Hassan H; Adam SK; Alias E; Meor Mohd Affandi MMR; Shamsuddin AF; Basir R
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
    Shilpi D; Kushwah V; Agrawal AK; Jain S
    Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine.
    Singh G; Pai RS
    Drug Deliv; 2014 Dec; 21(8):627-35. PubMed ID: 24344769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Pluronic F-68 vs Tween 80 on Fabrication and Evaluation of Acyclovir SLNs for Skin Delivery.
    Bhupinder K; Newton MJ
    Recent Pat Drug Deliv Formul; 2016; 10(3):207-221. PubMed ID: 27456458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.